Projects per year
Fingerprint
Dive into the research topics where Jeffrey Tyner is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
-
-
Targeting PTPN11 dependent Hematologic Malignancies
Tyner, J., Chang, B., Chang, B. & Tyner, J.
Project: Research project
-
Mechanisms of venetoclax combination activity in acute myeloid leukemia
Project: Research project
-
Activation of RAS/MAPK pathway confers MCL-1 mediated acquired resistance to BCL-2 inhibitor venetoclax in acute myeloid leukemia
Zhang, Q., Riley-Gillis, B., Han, L., Jia, Y., Lodi, A., Zhang, H., Ganesan, S., Pan, R., Konoplev, S. N., Sweeney, S. R., Ryan, J. A., Jitkova, Y., Dunner, K., Grosskurth, S. E., Vijay, P., Ghosh, S., Lu, C., Ma, W., Kurtz, S., Ruvolo, V. R., & 21 others, Dec 2022, In: Signal Transduction and Targeted Therapy. 7, 1, 51.Research output: Contribution to journal › Article › peer-review
Open Access5 Scopus citations -
A genome-wide CRISPR screen identifies regulators of MAPK and MTOR pathways that mediate resistance to sorafenib in acute myeloid leukemia
Damnernsawad, A., Bottomly, D., Kurtz, S. E., Eide, C. A., McWeeney, S. K., Tyner, J. W. & Nechiporuk, T., Jan 2022, In: Haematologica. 107, 1, p. 77-85 9 p.Research output: Contribution to journal › Article › peer-review
Open Access5 Scopus citations -
Associating drug sensitivity with differentiation status identifies effective combinations for acute myeloid leukemia
Kurtz, S., Eide, C. A., Kaempf, A., Long, N., Bottomly, D., Nikolova, O., Druker, B. J., McWeeney, S. K., Chang, B. H., Tyner, J. W. & Agarwal, A., May 24 2022, In: Blood Advances. 6, 10, p. 3062-3067 6 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Correction: Activation of RAS/MAPK pathway confers MCL-1 mediated acquired resistance to BCL-2 inhibitor venetoclax in acute myeloid leukemia (Signal Transduction and Targeted Therapy, (2022), 7, 1, (51), 10.1038/s41392-021-00870-3)
Zhang, Q., Riley-Gillis, B., Han, L., Jia, Y., Lodi, A., Zhang, H., Ganesan, S., Pan, R., Konoplev, S. N., Sweeney, S. R., Ryan, J. A., Jitkova, Y., Dunner, K., Grosskurth, S. E., Vijay, P., Ghosh, S., Lu, C., Ma, W., Kurtz, S., Ruvolo, V. R., & 21 others, Dec 2022, In: Signal Transduction and Targeted Therapy. 7, 1, 110.Research output: Contribution to journal › Comment/debate › peer-review
Open Access -
Dual BTK/SYK inhibition with CG-806 (luxeptinib) disrupts B-cell receptor and Bcl-2 signaling networks in mantle cell lymphoma
Thieme, E., Liu, T., Bruss, N., Roleder, C., Lam, V., Wang, X., Nechiporuk, T., Shouse, G., Danilova, O. V., Bottomly, D., McWeeney, S. K., Tyner, J. W., Kurtz, S. E. & Danilov, A. V., Mar 2022, In: Cell Death and Disease. 13, 3, 246.Research output: Contribution to journal › Article › peer-review
Open Access